NRIX Stock Summary and Trading Ideas (Nurix Therapeutics | NASDAQ:NRIX)

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Nurix Therapeutics trades on the NASDAQ stock market under the symbol NRIX.

As of December 22, 2025, NRIX stock price climbed to $19.34 with 1,046,273 million shares trading.

NRIX has a beta of 1.20, meaning it tends to be more sensitive to market movements. NRIX has a correlation of 0.11 to the broad based SPY ETF.

NRIX has a market cap of $1.96 billion. This is considered a Small Cap stock.

Last quarter Nurix Therapeutics reported $8 million in Revenue and -$1.03 earnings per share. This fell short of revenue expectation by $-9 million and missed earnings estimates by -$.18.

In the last 3 years, NRIX traded as high as $29.56 and as low as $4.22.

The top ETF exchange traded funds that NRIX belongs to (by Net Assets): IWM, VTI, XBI, ARKG, VXF.

NRIX has underperformed the market in the last year with a return of -3.5%, while SPY returned +18.8%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in NRIX shares. However, NRIX has outperformed the market in the last 3 month and 2 week periods, returning +129.1% and +6.9%, while SPY returned +3.5% and +0.2%, respectively. This indicates NRIX has been having a stronger performance recently.

NRIX support price is $17.65 and resistance is $19.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NRIX shares will trade within this expected range on the day.